Skip to content
  • Spain
  • United Kingdom
  • Europe
  • United States
  • Japan
  • The Middle East
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Russia
  • Chile
  • Argentina
  • Turkey
  • USA
  • +1(305)501-4948 Request Information
  • +1(305)501-4948 Request Information
IGENOMIX – With science on your sideIGENOMIX – With science on your side
  • Education
    • Fertility
  • Services for health specialists
    • ERA
    • EndomeTRIO
    • EMMA
    • ALICE
    • COVID-19 PCR
    • PGT-A + ERA Synchrony
    • PGT-A
    • Family Balancing
    • EMBRACE
    • PGT-M
    • SAT
    • POC
    • Oncodona
  • Services for patients
    • ERA
    • EndomeTRIO
    • EMMA
    • ALICE
    • PGT-A + ERA Synchrony
    • PGT-A
    • Family Balancing
    • Embrace
    • PGT-M
    • SAT
    • POC
    • Oncodona
  • About us
    • Research & Igenomix Foundation
    • About Igenomix
  • Blog
    • Fertility Challenges
    • Patient Stories
  • WEBINARS
Our Services > Oncodona

Oncodona

A complete test of genetic screening that analyzes 21 genes related to breast and ovarian cancer.

  • Overview
  • Features
  • How does it Work?
  • I’m a health specialist

Early identification of predisposition to inherited cancer.

Results in 30 days.

Harmful mutations can be transmitted with a 50% probability.

Overview

What is Oncodona test?

  • Oncodona is the most advanced genetic test for early identification of predisposition to inherited cancer.
  • This test analyzes 21 genes related to breast and ovarian cancer in order to locate mutations that increase the risk of developing these types of cancer.
  • Oncodona uses Next Generation Sequencing (NGS) to analyze genetic information present in a panel of 21 genes, including BRCA1 and BRCA2 genes, in order to locate harmful mutations.
Features
  • Indications
  • Benefits

Is Oncodona for you?

This test is recommended if:

  • You’ve been diagnosed with breast cancer and BRCA1 and BRCA2 negative genetic test. Oncodona can find a mutation in up to 4% of women.
  • A woman in your family has been diagnosed with breast and ovarian cancer. 
  • You just want to know if you have any risk of developing breast and ovarian cancer.

Why use Oncodona?

  • The performance of the test, if positive, can be used to adopt follow-up and personalized early detection measures of the patient and their relatives.
  • A negative result means that the patient does not have an increased risk. In other words, their risk of suffering one of the types of cancer analysed by the test is the baseline risk of the population.
How does it work?

BROCHURE

Download
email

Subscribe to
our newsletter

  • *

Help us to improve

  • *

Other services you may be interested

Family Balancing

Have a healthy baby of your desired sex

More information

PGT-M

Prevents the transmission of single gene disorders

More information

PGT-A

Improves the chances of reproductive success by selecting chromosomally normal embryos

More information

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.

WE GUIDE YOU

Fertility
COVID-19 basic Q&A

 

OUR SERVICES

For Health Specialists
For Patients

ABOUT US

About Igenomix
Contact
Press and news
Work with us
Quality

FOLLOW IGENOMIX

Blog: Road to fertility

*CAP accreditation applies to the LA lab.

  +1 (305) 501-4948 
  Email us
  • Spain
  • United Kingdom
  • Europe
  • United States
  • Japan
  • The Middle East
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Russia
  • Chile
  • Argentina
  • Turkey
Language

[2019] © Igenomix Privacy policy & cookies policy Quality policy Terms & conditions User Feedback

Help us to improve

  • *

Request Information


  • reCAPTCHA demo: Simple page

  • Education
    • Fertility
  • Services for health specialists
    • ERA
    • EndomeTRIO
    • EMMA
    • ALICE
    • COVID-19 PCR
    • PGT-A + ERA Synchrony
    • PGT-A
    • Family Balancing
    • EMBRACE
    • PGT-M
    • SAT
    • POC
    • Oncodona
  • Services for patients
    • ERA
    • EndomeTRIO
    • EMMA
    • ALICE
    • PGT-A + ERA Synchrony
    • PGT-A
    • Family Balancing
    • Embrace
    • PGT-M
    • SAT
    • POC
    • Oncodona
  • About us
    • Research & Igenomix Foundation
    • About Igenomix
  • Blog
    • Fertility Challenges
    • Patient Stories
  • WEBINARS
  • USA